Literature DB >> 8383228

Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter.

M Carvalho1, D Derse.   

Abstract

Equine infectious anemia virus (EIAV) is a lentivirus that causes a chronic disease of horses characterized by cyclic episodes of fever, anemia, and viremia. Although the genome and promoter of EIAV are much less complex than those of its relatives the primate immunodeficiency viruses, the cellular proteins that activate and regulate transcription of EIAV have not yet been identified. In this report, we show by electrophoretic mobility shift assays and DNase I footprinting that the EIAV promoter contains multiple binding sites for ubiquitous, cell type-specific, and inducible cellular proteins. Functional analysis by transient transfection of canine osteosarcoma (D17) and human epithelial carcinoma (HeLa) cells with EIAV promoters containing deletions or individually mutated DNA-binding sites demonstrated that these DNA-binding elements cooperatively regulate transcriptional activity. A methylated DNA-binding site (MDBP; also designated EF-C or EP) acts as either a positive or negative regulator of promoter activity, depending on the cell type or condition. Two PEA2 elements, an AP-1 site, and an ets/PEA3 motif confer a positive effect on promoter activity. The EIAV promoter is shown to be activated by treatment of HeLa cells with phorbol myristate acetate (PMA). DNA-binding activities were induced in PMA-treated HeLa cells and formed complexes on oligonucleotides that contain the EIAV AP-1 and ets/PEA3 elements. Functional analysis of mutated promoters indicated that the ets/PEA3 motif was the principal mediator of PMA activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383228      PMCID: PMC240285     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Interaction of a nuclear factor with the polyomavirus enhancer region.

Authors:  P Ostapchuk; J F Diffley; J T Bruder; B Stillman; A J Levine; P Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  A cloned human immunoglobulin heavy chain gene with a novel direct-repeat sequence in 5' flanking region.

Authors:  A Kudo; T Ishihara; Y Nishimura; T Watanabe
Journal:  Gene       Date:  1985       Impact factor: 3.688

3.  JC virus enhancer-promoter active in human brain cells.

Authors:  S Kenney; V Natarajan; D Strike; G Khoury; N P Salzman
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

4.  Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.

Authors:  M H Kryszke; J Piette; M Yaniv
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

5.  Characterization of equine infectious anemia virus long terminal repeat.

Authors:  D Derse; P L Dorn; L Levy; R M Stephens; N R Rice; J W Casey
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

Review 6.  Equine infectious anemia virus: immunopathogenesis and persistence.

Authors:  W P Cheevers; T C McGuire
Journal:  Rev Infect Dis       Date:  1985 Jan-Feb

7.  Polyomavirus enhancer contains multiple redundant sequence elements that activate both DNA replication and gene expression.

Authors:  G M Veldman; S Lupton; R Kamen
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

8.  Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation.

Authors:  J L Hess; J A Small; J E Clements
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

9.  Biological and biochemical studies of African green monkey lymphotropic papovavirus.

Authors:  K K Takemoto; A Furuno; K Kato; K Yoshiike
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

10.  Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers.

Authors:  J Piette; M Yaniv
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

View more
  11 in total

1.  Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.

Authors:  W Maury; S Perryman; J L Oaks; B K Seid; T Crawford; T McGuire; S Carpenter
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.

Authors:  R Taube; K Fujinaga; D Irwin; J Wimmer; M Geyer; B M Peterlin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.

Authors:  Wendy Maury; Robert J Thompson; Quentin Jones; Sarahann Bradley; Tara Denke; Prasith Baccam; Matthew Smazik; J Lindsay Oaks
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Disease induction by virus derived from molecular clones of equine infectious anemia virus.

Authors:  S L Payne; X M Qi; H Shao; A Dwyer; F J Fuller
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Monocyte maturation controls expression of equine infectious anemia virus.

Authors:  W Maury
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

6.  The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activity.

Authors:  M Carvalho; M Kirkland; D Derse
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.

Authors:  R F Cook; C Leroux; S J Cook; S L Berger; D L Lichtenstein; N N Ghabrial; R C Montelaro; C J Issel
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 9.  Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses.

Authors:  Lorena de Pablo-Maiso; Ana Doménech; Irache Echeverría; Carmen Gómez-Arrebola; Damián de Andrés; Sergio Rosati; Esperanza Gómez-Lucia; Ramsés Reina
Journal:  Viruses       Date:  2018-08-17       Impact factor: 5.048

10.  Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo.

Authors:  Xue-Feng Wang; Qiang Liu; Yu-Hong Wang; Shuai Wang; Jie Chen; Yue-Zhi Lin; Jian Ma; Jian-Hua Zhou; Xiaojun Wang
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.